Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    PALO-10-20
Show Display Options
Rank Status Study
1 Completed
Has Results
Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients
Condition: Chemotherapy-Induced Nausea and Vomiting
Interventions: Drug: Palonosetron;   Drug: Ondansetron;   Drug: Placebo to Ondansetron;   Drug: Placebo to Palonosetron

Study has passed its completion date and status has not been verified in more than two years.